The prevalence of age-related maculopathy (ARM) in an urban Norwegian population: The Oslo macular study

Acta Ophthalmologica Scandinavica

Volumn 84, Issue 5, 2006, Pages 636-641

  Björnsson, Ólafur M ^a,c   Syrdalen, Per ^a   Bird, Alan C ^b   Peto, Tundo ^b   Kinge, Bettina ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c NONE   (Iceland)

Author keywords

Age related macular degeneration; Age related maculopathy; Digital fundus photography; Drusen; Epidemiology; Macula; Prevalence

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUSEN; EYE PHOTOGRAPHY; FEMALE; HUMAN; HYPERPIGMENTATION; MAJOR CLINICAL STUDY; MALE; NORWAY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULOPATHY; RETINA PIGMENT DEGENERATION; URBAN POPULATION;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; NORWAY; PHOTOGRAPHY; PREVALENCE; REGISTRIES; URBAN POPULATION;

EID: 33748264547     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2006.00696.x     Document Type: Article

References (26)

1. Algvere PV & Seregard S (2002): Age-related maculopathy: pathogenetic features and new treatment modalities. Acta Ophthalmol Scand 80: 136-143.
2. Age-Related Eye Disease Study (AREDS) Group (2001): A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene and zinc for age-related macular degeneration and vision loss. AREDS Report 8. Arch Ophthalmol 119: 1417-1436.
3. Bird AC, Bressler NM, Bressler SB et.al. (1995): An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39: 367-374.
4. Bressler NM (2001): Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: 2-year results of two randomized clinical trials. TAP Report 2. Arch Ophthalmol 119: 198-207.
5. Chylack LT Jr, Wolfe JK, Singer DM et.al. (1993): The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol 111: 831-836.
6. D'Amico DJ, Goldberg MF, Hudson H et.al. (2003): Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: 12-month clinical outcomes. Ophthalmology 110: 2372-2383.
7. Hyman L, (2004): Epidemiology of AMD. In: Hampton GR & Nelsen PT (eds). Age-related Macular Degeneration: Principles and Practices. New York: Raven Press 9-12.
8. Jonasson F, Arnarsson A, Sasaki H, Peto T, Sasaki K & Bird AC (2003): The prevalence of age-related maculopathy in Iceland: Reykjavik Eye Study. Arch Ophthalmol 121: 379-385.
9. Karel I & Zahlava J (2002): [Transpupillary thermotherapy in age-related macular degeneration with choroidal membrane neovascularization.] Cesk Slov Oftalmol 58: 274-277.
10. Kinge B, Midelfart A & Jacobsen G (1998): Refractive errors among young adults and university students in Norway. Acta Ophthalmol Scand 76: 692-695.
11. Klein R, Klein BE & Linton KL (1992): Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 99: 933-943.
12. Klein R, Meuer SM, Moss SE, Klein BE, Neider MW & Reinke J (2004): Detection of age-related macular degeneration using a non-mydriatic digital camera and a standard film fundus camera. Arch Ophthalmol 122: 1642-1646.
13. Laatikainen L & Hirvela H (1995): Prevalence and visual consequences of macular changes in a population aged 70 years and older. Acta Ophthalmol Scand 73: 105-110.
14. Landis JR & Koch GG (1977): The measurement of observer agreement for categorical data. Biometrics 33: 159-174.
15. van Leeuweu R, Chakravarthy U, Vingerling JR, Brussee C, Hooghart AJ, Mulder PG & de Jong PT (2003): Grading of age-related maculopathy for epidemiological studies: Is digital imaging as good as 35-mm film? Ophthalmology 110: 1540-1544.
16. Midelfart A, Kinge B, Midelfart S & Lydersen S (2002): Prevalence of refractive errors in young and middle-aged adults in Norway. Acta Ophthalmol Scand 80: 501-505.
17. Mitchell P, Smith W, Attebo K & Wang JJ (1995): Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 102: 1450-1460.
18. Newsom RS, McAlister JC, Saeed M & McHugh JD (2001): Transpupillary thermotherapy (TTT) for the treatment of choroidal neovascularization. Br J Ophthalmol 85: 173-178.
19. Pagliarini S, Moramarco A, Wormald RP, Piguet B, Carresi C, Balacco-Gabrieli C, Sehmi KS & Bird AC (1997): Age-related macular disease in rural southern Italy. Arch Ophthalmol 115: 616-622.
20. Rutishouser-Arnold Y, al-Rawi H, Bunce C, Xing W, Webster AR, Bird AC & Peto T (2004): A comparison of stereoscopic fundus colour slides with digital non-stereoscopic fundus photographs for grading in age-related maculopathy and macular degeneration. Paper presented at the Association for Research in Vision and Ophthalmology Annual Meeting, Fort Lauderdale, FL, USA, 2004.
21. Scholl HP, Dandekar SS, Peto T, Bunce C, Xing W, Jenkins S & Bird AC (2004): What is lost by digitizing stereoscopic fundus colour slides for macular grading in age-related maculopathy and degeneration? Ophthalmology 111: 125-132.
22. Stein JD, Brown MM, Brown GC, Hollands H & Sharma S (2003): Quality of life with macular degeneration: Perceptions of patients, clinicians and community members. Br J Ophthalmol 87: 8-12.
23. Van Newkirk MR, Nanjan MB, Wang JJ, Mitchell P, Taylor HR & McCarty CA (2000): The prevalence of age-relaTed maculopathy: the visual impairment project. Ophthalmology 107: 1593-1600.
24. Vinding T (1995): Age-related macular degeneration. An epidemiological study of 1000 elderly individuals. With reference to prevalence, funduscopic findings, visual impairment and risk factors. Acta Ophthalmol Scand 73 (Suppl): 1-32.
25. Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CF & de Jong PT (1995): The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 102: 205-210.
26. Wright SE, Keeffe JE & Thies LS (2000): Direct costs of blindness in Australia. Clin Exp Ophthalmol 28: 140-142.